Glycogen synthase kinase-3 inhibitor as a multi-targeting anti-rheumatoid drug

Medicine and Dentistry

• Rheumatoid Arthritis 100%
• Glycogen Synthase Kinase 3 50%
• Development 33%
• Drug 33%
• Chemotherapeutic Agent 33%
• Cells 16%
• Serositis 16%
• Patient 16%
• Pathogenesis 16%
• Pain 16%
• Diseases 16%
• Disability 16%
• Swelling 16%
• Antibody 16%
• Comprehension 16%
• Pathology 16%
• Quality of Life 16%
• Protein Serine Threonine Kinase 16%
• Tumor Necrosis Factor 16%
• Arthropathy 16%
• Drug Delivery System 16%
• Glycogen Synthase Kinase 3 Inhibitor 16%
• Bone Erosion 16%
• Osteoporosis 16%